IDEXX Laboratories Past Earnings Performance
Past criteria checks 6/6
IDEXX Laboratories has been growing earnings at an average annual rate of 14.9%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 10.5% per year. IDEXX Laboratories's return on equity is 55.2%, and it has net margins of 23.3%.
Key information
14.9%
Earnings growth rate
15.8%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 10.5% |
| Return on equity | 55.2% |
| Net Margin | 23.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How IDEXX Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,725 | 867 | 925 | 199 |
| 31 Dec 23 | 3,661 | 845 | 902 | 191 |
| 30 Sep 23 | 3,588 | 823 | 888 | 183 |
| 30 Jun 23 | 3,514 | 791 | 877 | 183 |
| 31 Mar 23 | 3,431 | 699 | 858 | 259 |
| 31 Dec 22 | 3,367 | 679 | 851 | 255 |
| 30 Sep 22 | 3,340 | 670 | 848 | 257 |
| 30 Jun 22 | 3,309 | 664 | 840 | 249 |
| 31 Mar 22 | 3,274 | 735 | 821 | 164 |
| 31 Dec 21 | 3,215 | 745 | 796 | 161 |
| 30 Sep 21 | 3,135 | 757 | 770 | 154 |
| 30 Jun 21 | 3,047 | 728 | 777 | 152 |
| 31 Mar 21 | 2,858 | 674 | 739 | 146 |
| 31 Dec 20 | 2,707 | 582 | 735 | 141 |
| 30 Sep 20 | 2,591 | 497 | 717 | 138 |
| 30 Jun 20 | 2,475 | 460 | 674 | 134 |
| 31 Mar 20 | 2,457 | 437 | 681 | 135 |
| 31 Dec 19 | 2,407 | 428 | 669 | 133 |
| 30 Sep 19 | 2,351 | 423 | 657 | 128 |
| 30 Jun 19 | 2,291 | 407 | 642 | 123 |
| 31 Mar 19 | 2,252 | 390 | 638 | 120 |
| 31 Dec 18 | 2,213 | 377 | 632 | 118 |
| 30 Sep 18 | 2,170 | 330 | 621 | 117 |
| 30 Jun 18 | 2,117 | 307 | 610 | 115 |
| 31 Mar 18 | 2,045 | 284 | 596 | 112 |
| 31 Dec 17 | 1,969 | 263 | 575 | 109 |
| 30 Sep 17 | 1,906 | 277 | 561 | 106 |
| 30 Jun 17 | 1,862 | 263 | 547 | 104 |
| 31 Mar 17 | 1,820 | 245 | 534 | 102 |
| 31 Dec 16 | 1,775 | 222 | 522 | 101 |
| 30 Sep 16 | 1,732 | 214 | 516 | 101 |
| 30 Jun 16 | 1,690 | 202 | 502 | 100 |
| 31 Mar 16 | 1,637 | 192 | 493 | 99 |
| 31 Dec 15 | 1,602 | 192 | 482 | 100 |
| 30 Sep 15 | 1,554 | 174 | 475 | 99 |
| 30 Jun 15 | 1,531 | 182 | 467 | 99 |
| 31 Mar 15 | 1,508 | 182 | 457 | 100 |
| 31 Dec 14 | 1,486 | 182 | 448 | 98 |
| 30 Sep 14 | 1,488 | 199 | 435 | 96 |
| 30 Jun 14 | 1,443 | 193 | 422 | 93 |
| 31 Mar 14 | 1,405 | 190 | 409 | 89 |
| 31 Dec 13 | 1,377 | 188 | 401 | 88 |
| 30 Sep 13 | 1,343 | 188 | 381 | 87 |
| 30 Jun 13 | 1,320 | 185 | 370 | 85 |
Quality Earnings: IX1 has high quality earnings.
Growing Profit Margin: IX1's current net profit margins (23.3%) are higher than last year (20.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IX1's earnings have grown by 14.9% per year over the past 5 years.
Accelerating Growth: IX1's earnings growth over the past year (23.9%) exceeds its 5-year average (14.9% per year).
Earnings vs Industry: IX1 earnings growth over the past year (23.9%) exceeded the Medical Equipment industry -9.8%.
Return on Equity
High ROE: IX1's Return on Equity (55.2%) is considered outstanding.